Inhibition of NLRP3 inflammasome alleviates cognitive deficits in a mouse model of anti-NMDAR encephalitis induced by active immunization

Figure 6. Schematic illustration of the activated NLRP3 inflammasome and the therapeutic effects of MCC950 in anti-NMDAR encephalitis. Overactivated NLRP3 inflammasome and inflammatory response were detected in anti-NMDAR encephalitis mice model induced by active immunization, companied with the ove...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International immunopharmacology 2024-08, Vol.137, p.112374, Article 112374
Hauptverfasser: Yang, Xiaxin, Sun, Anqi, Kong, Liangbo, Yang, Xue, Zhao, Xiuhe, Wang, Shengjun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 112374
container_title International immunopharmacology
container_volume 137
creator Yang, Xiaxin
Sun, Anqi
Kong, Liangbo
Yang, Xue
Zhao, Xiuhe
Wang, Shengjun
description Figure 6. Schematic illustration of the activated NLRP3 inflammasome and the therapeutic effects of MCC950 in anti-NMDAR encephalitis. Overactivated NLRP3 inflammasome and inflammatory response were detected in anti-NMDAR encephalitis mice model induced by active immunization, companied with the overactivation of microglia. MCC950 had the potential protective effect to inhibit NLRP3 associated inflammatory cascade and alleviate the cognitive deficits in anti-NMDAR encephalitis mice model. NLRP3, the nucleotide-binding oligomerization domain like receptor family pyrin domain-containing 3; ASC, Apoptosis-associated speck-like protein containing a CARD; NEA, anti-NMDAR encephalitis mice model induced by active immunization; IL1β, interleukin 1β; IL18, interleukin 18. [Display omitted] •Cognitive dysfunction was found in the anti-NMDAR encephalitis mice model induced by active immunization with peptide GluN1356–385.•Overactivated NLRP3 inflammasome were firstly uncovered in the anti-NMDAR encephalitis mice model, leading to microglia overactivation and inflammatory cascade reaction.•MCC950, a specific inhibitor of the NLRP3 inflammasome, alleviated the inflammatory response and cognitive dysfunction in the anti-NMDAR encephalitis mice. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a neurological disorder, characterized by cognitive deficits as one of its vital features. The nucleotide-binding oligomerization domain-like receptor (NLRP3) inflammasome is a key contributor to neuroinflammation and cognitive deficits in neurological diseases. However, the underlying mechanism of anti-NMDAR encephalitis remains unclear, and the biological function of the NLRP3 inflammasome in this condition has not been elucidated. In this study, a mouse model of anti-NMDAR encephalitis was induced by active immunization with the GluN1356–385 peptide (NEA model). The NLRP3 inflammasome in the hippocampus and temporal cortex was investigated using real-time quantitative PCR (RT-qPCR), western blotting, and immunofluorescence staining. The impact of MCC950 on cognitive function and NLRP3 inflammation was assessed. Confocal immunofluorescence staining and Sholl analysis were employed to examine the function and morphology of microglia. In the current study, we discovered overactivation of the NLRP3 inflammasome and an enhanced inflammatory response in the NEA model, particularly in the hippocampus and temporal cortex. Furthermore, significant cognitive dysfunction was obs
doi_str_mv 10.1016/j.intimp.2024.112374
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3065985974</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1567576924008944</els_id><sourcerecordid>3065985974</sourcerecordid><originalsourceid>FETCH-LOGICAL-c241t-780c53fe5079e8086f766d19256aca5cd7474d5d501da87025639972789b88793</originalsourceid><addsrcrecordid>eNp9kc1u1TAQha0KRH_gDSrkJZvc2kn8t6lUtdBWuhRUwdrytSd0ruLkNk6uVN6At67TFJZsbGv0nTmeOYSccrbijMuz7Qq7EeNuVbKyXnFeVqo-IEdcK11wxcSb_BZSFUJJc0iOU9oylus1f0cOK60F57I8In9uuwfc4Ih9R_uG3q3vv1cUu6Z1MbrUR6CubWGPboREff-ry-geaIAGPY4po9TR2E8J8hmgnZu4_K_i7uvVxT2FzsPuwbVZNbNh8hDo5ok6_9IGY5w6_O1m-_fkbePaBB9e7xPy88vnH5c3xfrb9e3lxbrwZc3HQmnmRdWAYMqAZlo2SsrATSmk8074oGpVBxEE48FpxXK9MkaVSpuN1spUJ-TT0nc39I8TpNFGTB7a1nWQ57AVk8JoYVSd0XpB_dCnNEBjdwNGNzxZzuwcgt3aJQQ7h2CXELLs46vDtIkQ_on-bj0D5wsAec49wmCTx3lVAQfwow09_t_hGRmomrY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3065985974</pqid></control><display><type>article</type><title>Inhibition of NLRP3 inflammasome alleviates cognitive deficits in a mouse model of anti-NMDAR encephalitis induced by active immunization</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Yang, Xiaxin ; Sun, Anqi ; Kong, Liangbo ; Yang, Xue ; Zhao, Xiuhe ; Wang, Shengjun</creator><creatorcontrib>Yang, Xiaxin ; Sun, Anqi ; Kong, Liangbo ; Yang, Xue ; Zhao, Xiuhe ; Wang, Shengjun</creatorcontrib><description>Figure 6. Schematic illustration of the activated NLRP3 inflammasome and the therapeutic effects of MCC950 in anti-NMDAR encephalitis. Overactivated NLRP3 inflammasome and inflammatory response were detected in anti-NMDAR encephalitis mice model induced by active immunization, companied with the overactivation of microglia. MCC950 had the potential protective effect to inhibit NLRP3 associated inflammatory cascade and alleviate the cognitive deficits in anti-NMDAR encephalitis mice model. NLRP3, the nucleotide-binding oligomerization domain like receptor family pyrin domain-containing 3; ASC, Apoptosis-associated speck-like protein containing a CARD; NEA, anti-NMDAR encephalitis mice model induced by active immunization; IL1β, interleukin 1β; IL18, interleukin 18. [Display omitted] •Cognitive dysfunction was found in the anti-NMDAR encephalitis mice model induced by active immunization with peptide GluN1356–385.•Overactivated NLRP3 inflammasome were firstly uncovered in the anti-NMDAR encephalitis mice model, leading to microglia overactivation and inflammatory cascade reaction.•MCC950, a specific inhibitor of the NLRP3 inflammasome, alleviated the inflammatory response and cognitive dysfunction in the anti-NMDAR encephalitis mice. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a neurological disorder, characterized by cognitive deficits as one of its vital features. The nucleotide-binding oligomerization domain-like receptor (NLRP3) inflammasome is a key contributor to neuroinflammation and cognitive deficits in neurological diseases. However, the underlying mechanism of anti-NMDAR encephalitis remains unclear, and the biological function of the NLRP3 inflammasome in this condition has not been elucidated. In this study, a mouse model of anti-NMDAR encephalitis was induced by active immunization with the GluN1356–385 peptide (NEA model). The NLRP3 inflammasome in the hippocampus and temporal cortex was investigated using real-time quantitative PCR (RT-qPCR), western blotting, and immunofluorescence staining. The impact of MCC950 on cognitive function and NLRP3 inflammation was assessed. Confocal immunofluorescence staining and Sholl analysis were employed to examine the function and morphology of microglia. In the current study, we discovered overactivation of the NLRP3 inflammasome and an enhanced inflammatory response in the NEA model, particularly in the hippocampus and temporal cortex. Furthermore, significant cognitive dysfunction was observed in the NEA model. While, MCC950, a selective inhibitor of the NLRP3 inflammasome, sharply attenuated the inflammatory response in mice, leading to mitigated cognitive deficits of mice and more regular arrangements of neurons and reduced number of hyperchromatic cells were also observed in the hippocampus area. In addition, we found that the excess elevation of NLRP3 inflammasome was mainly expressed in microglia accompanied with the overactivation of microglia, while MCC950 treatment significantly inhibited the increased number and activated morphological changes of microglia in the NEA model. Altogether, our study reveals the vital role of overactivated NLRP3 signaling pathway in aggravating the inflammatory response and cognitive deficits and the potential protective effect of MCC950 in anti-NMDAR encephalitis. Thus, MCC950 represents a promising strategy for anti-inflammation in anti-NMDAR encephalitis and our study lays a theoretical foundation for it to become a clinically targeted drug.</description><identifier>ISSN: 1567-5769</identifier><identifier>ISSN: 1878-1705</identifier><identifier>EISSN: 1878-1705</identifier><identifier>DOI: 10.1016/j.intimp.2024.112374</identifier><identifier>PMID: 38851162</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Anti-NMDAR encephalitis ; Cognitive dysfunction ; MCC950 ; Microglia ; Neuroinflammation ; NLRP3 inflammasome</subject><ispartof>International immunopharmacology, 2024-08, Vol.137, p.112374, Article 112374</ispartof><rights>2024</rights><rights>Copyright © 2024. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c241t-780c53fe5079e8086f766d19256aca5cd7474d5d501da87025639972789b88793</cites><orcidid>0000-0002-5053-5180</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.intimp.2024.112374$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38851162$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Xiaxin</creatorcontrib><creatorcontrib>Sun, Anqi</creatorcontrib><creatorcontrib>Kong, Liangbo</creatorcontrib><creatorcontrib>Yang, Xue</creatorcontrib><creatorcontrib>Zhao, Xiuhe</creatorcontrib><creatorcontrib>Wang, Shengjun</creatorcontrib><title>Inhibition of NLRP3 inflammasome alleviates cognitive deficits in a mouse model of anti-NMDAR encephalitis induced by active immunization</title><title>International immunopharmacology</title><addtitle>Int Immunopharmacol</addtitle><description>Figure 6. Schematic illustration of the activated NLRP3 inflammasome and the therapeutic effects of MCC950 in anti-NMDAR encephalitis. Overactivated NLRP3 inflammasome and inflammatory response were detected in anti-NMDAR encephalitis mice model induced by active immunization, companied with the overactivation of microglia. MCC950 had the potential protective effect to inhibit NLRP3 associated inflammatory cascade and alleviate the cognitive deficits in anti-NMDAR encephalitis mice model. NLRP3, the nucleotide-binding oligomerization domain like receptor family pyrin domain-containing 3; ASC, Apoptosis-associated speck-like protein containing a CARD; NEA, anti-NMDAR encephalitis mice model induced by active immunization; IL1β, interleukin 1β; IL18, interleukin 18. [Display omitted] •Cognitive dysfunction was found in the anti-NMDAR encephalitis mice model induced by active immunization with peptide GluN1356–385.•Overactivated NLRP3 inflammasome were firstly uncovered in the anti-NMDAR encephalitis mice model, leading to microglia overactivation and inflammatory cascade reaction.•MCC950, a specific inhibitor of the NLRP3 inflammasome, alleviated the inflammatory response and cognitive dysfunction in the anti-NMDAR encephalitis mice. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a neurological disorder, characterized by cognitive deficits as one of its vital features. The nucleotide-binding oligomerization domain-like receptor (NLRP3) inflammasome is a key contributor to neuroinflammation and cognitive deficits in neurological diseases. However, the underlying mechanism of anti-NMDAR encephalitis remains unclear, and the biological function of the NLRP3 inflammasome in this condition has not been elucidated. In this study, a mouse model of anti-NMDAR encephalitis was induced by active immunization with the GluN1356–385 peptide (NEA model). The NLRP3 inflammasome in the hippocampus and temporal cortex was investigated using real-time quantitative PCR (RT-qPCR), western blotting, and immunofluorescence staining. The impact of MCC950 on cognitive function and NLRP3 inflammation was assessed. Confocal immunofluorescence staining and Sholl analysis were employed to examine the function and morphology of microglia. In the current study, we discovered overactivation of the NLRP3 inflammasome and an enhanced inflammatory response in the NEA model, particularly in the hippocampus and temporal cortex. Furthermore, significant cognitive dysfunction was observed in the NEA model. While, MCC950, a selective inhibitor of the NLRP3 inflammasome, sharply attenuated the inflammatory response in mice, leading to mitigated cognitive deficits of mice and more regular arrangements of neurons and reduced number of hyperchromatic cells were also observed in the hippocampus area. In addition, we found that the excess elevation of NLRP3 inflammasome was mainly expressed in microglia accompanied with the overactivation of microglia, while MCC950 treatment significantly inhibited the increased number and activated morphological changes of microglia in the NEA model. Altogether, our study reveals the vital role of overactivated NLRP3 signaling pathway in aggravating the inflammatory response and cognitive deficits and the potential protective effect of MCC950 in anti-NMDAR encephalitis. Thus, MCC950 represents a promising strategy for anti-inflammation in anti-NMDAR encephalitis and our study lays a theoretical foundation for it to become a clinically targeted drug.</description><subject>Anti-NMDAR encephalitis</subject><subject>Cognitive dysfunction</subject><subject>MCC950</subject><subject>Microglia</subject><subject>Neuroinflammation</subject><subject>NLRP3 inflammasome</subject><issn>1567-5769</issn><issn>1878-1705</issn><issn>1878-1705</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1TAQha0KRH_gDSrkJZvc2kn8t6lUtdBWuhRUwdrytSd0ruLkNk6uVN6At67TFJZsbGv0nTmeOYSccrbijMuz7Qq7EeNuVbKyXnFeVqo-IEdcK11wxcSb_BZSFUJJc0iOU9oylus1f0cOK60F57I8In9uuwfc4Ih9R_uG3q3vv1cUu6Z1MbrUR6CubWGPboREff-ry-geaIAGPY4po9TR2E8J8hmgnZu4_K_i7uvVxT2FzsPuwbVZNbNh8hDo5ok6_9IGY5w6_O1m-_fkbePaBB9e7xPy88vnH5c3xfrb9e3lxbrwZc3HQmnmRdWAYMqAZlo2SsrATSmk8074oGpVBxEE48FpxXK9MkaVSpuN1spUJ-TT0nc39I8TpNFGTB7a1nWQ57AVk8JoYVSd0XpB_dCnNEBjdwNGNzxZzuwcgt3aJQQ7h2CXELLs46vDtIkQ_on-bj0D5wsAec49wmCTx3lVAQfwow09_t_hGRmomrY</recordid><startdate>20240820</startdate><enddate>20240820</enddate><creator>Yang, Xiaxin</creator><creator>Sun, Anqi</creator><creator>Kong, Liangbo</creator><creator>Yang, Xue</creator><creator>Zhao, Xiuhe</creator><creator>Wang, Shengjun</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5053-5180</orcidid></search><sort><creationdate>20240820</creationdate><title>Inhibition of NLRP3 inflammasome alleviates cognitive deficits in a mouse model of anti-NMDAR encephalitis induced by active immunization</title><author>Yang, Xiaxin ; Sun, Anqi ; Kong, Liangbo ; Yang, Xue ; Zhao, Xiuhe ; Wang, Shengjun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c241t-780c53fe5079e8086f766d19256aca5cd7474d5d501da87025639972789b88793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Anti-NMDAR encephalitis</topic><topic>Cognitive dysfunction</topic><topic>MCC950</topic><topic>Microglia</topic><topic>Neuroinflammation</topic><topic>NLRP3 inflammasome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Xiaxin</creatorcontrib><creatorcontrib>Sun, Anqi</creatorcontrib><creatorcontrib>Kong, Liangbo</creatorcontrib><creatorcontrib>Yang, Xue</creatorcontrib><creatorcontrib>Zhao, Xiuhe</creatorcontrib><creatorcontrib>Wang, Shengjun</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International immunopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Xiaxin</au><au>Sun, Anqi</au><au>Kong, Liangbo</au><au>Yang, Xue</au><au>Zhao, Xiuhe</au><au>Wang, Shengjun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of NLRP3 inflammasome alleviates cognitive deficits in a mouse model of anti-NMDAR encephalitis induced by active immunization</atitle><jtitle>International immunopharmacology</jtitle><addtitle>Int Immunopharmacol</addtitle><date>2024-08-20</date><risdate>2024</risdate><volume>137</volume><spage>112374</spage><pages>112374-</pages><artnum>112374</artnum><issn>1567-5769</issn><issn>1878-1705</issn><eissn>1878-1705</eissn><abstract>Figure 6. Schematic illustration of the activated NLRP3 inflammasome and the therapeutic effects of MCC950 in anti-NMDAR encephalitis. Overactivated NLRP3 inflammasome and inflammatory response were detected in anti-NMDAR encephalitis mice model induced by active immunization, companied with the overactivation of microglia. MCC950 had the potential protective effect to inhibit NLRP3 associated inflammatory cascade and alleviate the cognitive deficits in anti-NMDAR encephalitis mice model. NLRP3, the nucleotide-binding oligomerization domain like receptor family pyrin domain-containing 3; ASC, Apoptosis-associated speck-like protein containing a CARD; NEA, anti-NMDAR encephalitis mice model induced by active immunization; IL1β, interleukin 1β; IL18, interleukin 18. [Display omitted] •Cognitive dysfunction was found in the anti-NMDAR encephalitis mice model induced by active immunization with peptide GluN1356–385.•Overactivated NLRP3 inflammasome were firstly uncovered in the anti-NMDAR encephalitis mice model, leading to microglia overactivation and inflammatory cascade reaction.•MCC950, a specific inhibitor of the NLRP3 inflammasome, alleviated the inflammatory response and cognitive dysfunction in the anti-NMDAR encephalitis mice. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a neurological disorder, characterized by cognitive deficits as one of its vital features. The nucleotide-binding oligomerization domain-like receptor (NLRP3) inflammasome is a key contributor to neuroinflammation and cognitive deficits in neurological diseases. However, the underlying mechanism of anti-NMDAR encephalitis remains unclear, and the biological function of the NLRP3 inflammasome in this condition has not been elucidated. In this study, a mouse model of anti-NMDAR encephalitis was induced by active immunization with the GluN1356–385 peptide (NEA model). The NLRP3 inflammasome in the hippocampus and temporal cortex was investigated using real-time quantitative PCR (RT-qPCR), western blotting, and immunofluorescence staining. The impact of MCC950 on cognitive function and NLRP3 inflammation was assessed. Confocal immunofluorescence staining and Sholl analysis were employed to examine the function and morphology of microglia. In the current study, we discovered overactivation of the NLRP3 inflammasome and an enhanced inflammatory response in the NEA model, particularly in the hippocampus and temporal cortex. Furthermore, significant cognitive dysfunction was observed in the NEA model. While, MCC950, a selective inhibitor of the NLRP3 inflammasome, sharply attenuated the inflammatory response in mice, leading to mitigated cognitive deficits of mice and more regular arrangements of neurons and reduced number of hyperchromatic cells were also observed in the hippocampus area. In addition, we found that the excess elevation of NLRP3 inflammasome was mainly expressed in microglia accompanied with the overactivation of microglia, while MCC950 treatment significantly inhibited the increased number and activated morphological changes of microglia in the NEA model. Altogether, our study reveals the vital role of overactivated NLRP3 signaling pathway in aggravating the inflammatory response and cognitive deficits and the potential protective effect of MCC950 in anti-NMDAR encephalitis. Thus, MCC950 represents a promising strategy for anti-inflammation in anti-NMDAR encephalitis and our study lays a theoretical foundation for it to become a clinically targeted drug.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>38851162</pmid><doi>10.1016/j.intimp.2024.112374</doi><orcidid>https://orcid.org/0000-0002-5053-5180</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1567-5769
ispartof International immunopharmacology, 2024-08, Vol.137, p.112374, Article 112374
issn 1567-5769
1878-1705
1878-1705
language eng
recordid cdi_proquest_miscellaneous_3065985974
source ScienceDirect Journals (5 years ago - present)
subjects Anti-NMDAR encephalitis
Cognitive dysfunction
MCC950
Microglia
Neuroinflammation
NLRP3 inflammasome
title Inhibition of NLRP3 inflammasome alleviates cognitive deficits in a mouse model of anti-NMDAR encephalitis induced by active immunization
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T21%3A51%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20NLRP3%20inflammasome%20alleviates%20cognitive%20deficits%20in%20a%20mouse%20model%20of%20anti-NMDAR%20encephalitis%20induced%20by%20active%20immunization&rft.jtitle=International%20immunopharmacology&rft.au=Yang,%20Xiaxin&rft.date=2024-08-20&rft.volume=137&rft.spage=112374&rft.pages=112374-&rft.artnum=112374&rft.issn=1567-5769&rft.eissn=1878-1705&rft_id=info:doi/10.1016/j.intimp.2024.112374&rft_dat=%3Cproquest_cross%3E3065985974%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3065985974&rft_id=info:pmid/38851162&rft_els_id=S1567576924008944&rfr_iscdi=true